Walleye Trading’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$927 Hold
79,942
﹤0.01% 4020
2025
Q4
$863 Hold
79,942
﹤0.01% 4235
2025
Q3
$2.1K Sell
79,942
-50,230
-39% -$1.33K ﹤0.01% 4274
2025
Q2
$3.75K Sell
130,172
-1,100
-0.8% -$24 ﹤0.01% 4107
2025
Q1
$1.42K Sell
131,272
-2,909
-2% -$76 ﹤0.01% 3941
2024
Q4
$2.95K Buy
134,181
+61,621
+85% +$1.47K ﹤0.01% 4105
2024
Q3
$1.09K Hold
72,560
﹤0.01% 3975
2024
Q2
$2.18K Hold
72,560
﹤0.01% 4057
2024
Q1
$1.85K Hold
72,560
﹤0.01% 4533
2023
Q4
$2.25K Hold
72,560
﹤0.01% 4812
2023
Q3
$1.64K Hold
72,560
﹤0.01% 4807
2023
Q2
$5.2K Hold
72,560
﹤0.01% 4344
2023
Q1
$10.7K Hold
72,560
﹤0.01% 4355
2022
Q4
$7.25K Buy
72,560
+360
+0.5% +$24 ﹤0.01% 4530
2022
Q3
$2K Hold
72,200
﹤0.01% 4791
2022
Q2
$3K Buy
72,200
+14,000
+24% +$1.05K ﹤0.01% 4875
2022
Q1
$5K Hold
58,200
﹤0.01% 5098
2021
Q4
$19K Hold
58,200
﹤0.01% 4943
2021
Q3
$15K Hold
58,200
﹤0.01% 4930
2021
Q2
$31K Hold
58,200
﹤0.01% 4749
2021
Q1
$25K Buy
58,200
+8,000
+16% +$7.51K ﹤0.01% 4496
2020
Q4
$69K Buy
+50,200
New +$46.3K ﹤0.01% 4075

Other funds holding COEPW

Walleye Trading's COEPW Position: Q1 2026 in Review

Walleye Trading held its Coeptis Therapeutics Warrants (COEPW) position steady in Q1 2026 at 79,942 shares worth $927. The position accounts for ﹤0.01% of the portfolio, ranked #4020.

Walleye Trading first reported a position in COEPW in Q4 2020 and has held it in 22 quarters since. The position peaked at $69K in Q4 2020. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.

  • Walleye Trading held 79,942 shares of Coeptis Therapeutics Warrants worth $927 as of Q1 2026.
  • Walleye Trading left its Coeptis Therapeutics Warrants share count unchanged in Q1 2026.
  • Coeptis Therapeutics Warrants made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #4020 holding.
  • Walleye Trading first reported a position in Coeptis Therapeutics Warrants in Q4 2020 and has held it in 22 quarters since.
  • Walleye Trading's Coeptis Therapeutics Warrants position peaked at $69K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.